Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Mar 1;177(3):839-43.
doi: 10.1084/jem.177.3.839.

Adhesion to fibronectin prolongs eosinophil survival

Affiliations

Adhesion to fibronectin prolongs eosinophil survival

A R Anwar et al. J Exp Med. .

Abstract

We have investigated the effect of adhesion to fibronectin (Fn) on the survival of eosinophils in culture. Peripheral blood eosinophils from normal human donors were separated by immunomagnetic selection and cultured in RPMI on Fn- (100 micrograms/ml) coated microtiter plates for up to 96 h. Survival was measured by trypan blue exclusion. There was a significant enhancement of eosinophil survival with Fn as compared with both bovine serum albumin-coated and uncoated wells (p < 0.05-0.01). Fn-induced eosinophil survival was comparable to that obtained with exogenous interleukin 3 (IL-3) or granulocyte/macrophage colony-stimulating factor (GM-CSF) and was inhibitable by antibodies against Fn, very late antigen 4 (VLA-4), IL-3, and GM-CSF. Supernatants from Fn-, but not BSA-coated wells contained picogram amounts of IL-3 and GM-CSF, and eosinophils cultured on Fn for 24 h expressed mRNA for GM-CSF as determined by in situ hybridization. Therefore, Fn prolongs eosinophil survival in culture by triggering autocrine generation of cytokines by eosinophils. Since neutrophils lack VLA-4, this could provide a partial explanation for the preferential accumulation of eosinophils at sites of allergic inflammation, as well as the predominant tissue localization of eosinophils in healthy individuals.

PubMed Disclaimer

References

    1. Trans R Soc Trop Med Hyg. 1983;77(3):363-71 - PubMed
    1. J Immunol. 1992 Jun 1;148(11):3543-9 - PubMed
    1. J Exp Med. 1987 Jul 1;166(1):129-41 - PubMed
    1. J Immunol. 1989 Mar 15;142(6):1970-6 - PubMed
    1. J Biol Chem. 1990 Mar 5;265(7):4020-4 - PubMed

Publication types

MeSH terms